BioCentury
ARTICLE | Company News

Management tracks: CRISPR, Hua

December 22, 2017 11:02 PM UTC

Gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP) appointed Rodger Novak as chairman of the board. He succeeds Tony Coles, who will remain as a senior adviser. Novak is founder and president of CRISPR, and served as the company's CEO until Dec. 1 (see BioCentury Extra, Oct. 3).

Diabetes company Hua Medicine Ltd. (Shanghai, China) hired George Lin as EVP and CFO. He was head of consumer, retail and healthcare investment banking for Asia Pacific and head of investment banking coverage for Hong Kong and Taiwan at Bank of America Corporation (NYSE:BAC)...